AMO (Advanced Medical Optics) closes Pfizer deal:
This article was originally published in Clinica
Advanced Medical Optics (AMO) has completed the purchase of Pfizer's ophthalmic surgical business. Santa Ana, California-based AMO had agreed at the end of April this year to acquire the Pfizer unit in a $450m all-cash transaction (see Clinica No 1105, p 19). Through this deal, AMO's portfolio will be significantly boosted with the addition of Pfizer's CeeOn and Tecnis lines of intraocular lenses, its Healon family of viscoelastic products and the Baerveldt glaucoma shunt.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.